Company profile: Biorez
1.1 - Company Overview
Company description
- Provider of biocomposite implants for tendon and ligament repair, focused on advancing healing. Offers BioBrace Reinforced Implant combining synthetic and biologic materials to provide supplemental strength and facilitate healing in tendon and ligament repairs, available in two sizes: 5mm x 250mm and 23mm x 30mm.
Products and services
- BioBrace Reinforced Implant (23mm x 30mm): A biocomposite component combining synthetic and biologic materials, engineered to deliver supplemental strength and facilitate healing specifically in tendon and ligament repair applications
- BioBrace Reinforced Implant (5mm x 250mm): A biocomposite product merging synthetic and biologic materials, constructed to deliver supplemental strength and promote healing during tendon and ligament repairs
- Tendon and Ligament Healing Development: A medicine-focused capability centered on developing tendon and ligament healing, emphasizing facilitation of repairs and healing in these tissues
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biorez
Vertera Spine
HQ: United States
Website
- Description: Provider of a medical platform focused on commercializing and developing unique spine solutions featuring proprietary PEEK Scoria technology; developed by engineers and researchers at the Georgia Institute of Technology, founded in 2013 and headquartered in Georgia, USA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vertera Spine company profile →
Pristine Surgical
HQ: United States
Website
- Description: Provider of a first-of-its-kind single-use visualization platform for surgical and diagnostic rigid endoscopic procedures, including Summit, a 4K single-use arthroscope, and Pristine Connect cloud software for operational efficiency, automated inventory management, and digital training. Offers a subscription pricing model with transparent pricing and is developing a full portfolio of rigid and flexible endoscopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pristine Surgical company profile →
BioPoly
HQ: United States
Website
- Description: Provider of orthopedic devices serving the sports medicine, orthopedics, and spinal markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioPoly company profile →
Responsive Orthopedics
HQ: United States
Website
- Description: Provider of low-cost hip and knee replacements for healthcare providers participating in federal programs to reduce the costs of hip and knee procedures. Founded in 2013 and based in Minneapolis; acquired in June 2016.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Responsive Orthopedics company profile →
RevBio
HQ: United States
Website
- Description: Provider of an injectable, self-setting, osteoconductive bone adhesive biomaterial that bonds bone to bone and bone to metal in wet surgical environments. TETRANITE is under FDA review for oral, craniofacial, orthopedic, and neurosurgical applications, including dental implant stabilization, cranial flap fixation, distal radius fracture repair, dental bone grafts, and dental and orthopaedic uses in pets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RevBio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biorez
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biorez
2.2 - Growth funds investing in similar companies to Biorez
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biorez
4.2 - Public trading comparable groups for Biorez
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →